Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease |
Graft vs. Host Disease, Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease | Phase4 | China | NCT06824103 |
RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi Arabia |
HR+/HER2- Early Breast Cancer | Saudi Arabia | NCT06797531 | |
A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants. |
Autoimmune and Chronic Inflammatory Diseases | Phase1 | United States | NCT07032272 |
NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice |
Paroxysmal Nocturnal Hemoglobinuria | Russia | NCT07036718 | |
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. |
Relapsing Multiple Sclerosis | Phase3 | Argentina Australia Belgium Canada Denmark France Greece Italy Mexico Portugal Slovakia South Africa Spain Switzerland United States View all |
NCT06846281 |
Pelacarsen Roll-over Extension Program |
Atherosclerotic Cardiovascular Disease | Phase3 | United States | NCT06875973 |
Long-term Follow up Local Registry Study of Kymriah in South Korea |
B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma | South Korea | NCT06785818 | |
Inclisiran Effectiveness in China: a Pragmatic Randomized Trial |
Coronary Heart Disease | Phase4 | China | NCT06941792 |
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. |
Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis, Glomerular Disease, Glomerulonephritis, IGA, Glomerulopathy, Immunoglobulin Disease | Phase3 | Argentina South Korea United States |
NCT06858319 |
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC |
Prostate Cancer | Phase3 | Australia China Hong Kong Japan Singapore Taiwan United Kingdom United States View all |
NCT06855277 |